December 31, 2018
December brought four life science IPOs on the NASDAQ, giving investors new opportunities to enter the market.
December 7, 2018
DiaMedica Therapeutics (NASDAQ:DMAC) (TSXV:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering in the...
September 27, 2018
Ahon Pharmaceutical a subsidiary of Shanghai Fosun Pharmaceutical (HKG:02196,SHA:600196) and DiaMedica Therapeutics (TSXV:DMA,OTCQB:DMCAF) entered into a license and collaboration agreement,...
May 1, 2017
DiaMedica Therapeutics received a patent for DM199 from the US Patent and Trademark Office.
April 13, 2017
Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some...